Anti-MEPCE monoclonal antibody

Pre-made anti-MEPCE monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MEPCE/MEPCE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2594-Ab-1/ GM-Tg-hg-IP2594-Ab-2Anti-Human MEPCE monoclonal antibodyHuman
GM-Tg-rg-IP2594-Ab-1/ GM-Tg-rg-IP2594-Ab-2Anti-Rat MEPCE monoclonal antibodyRat
GM-Tg-mg-IP2594-Ab-1/ GM-Tg-mg-IP2594-Ab-2Anti-Mouse MEPCE monoclonal antibodyMouse
GM-Tg-cynog-IP2594-Ab-1/ GM-Tg-cynog-IP2594-Ab-2Anti-Cynomolgus/ Rhesus macaque MEPCE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2594-Ab-1/ GM-Tg-felg-IP2594-Ab-2Anti-Feline MEPCE monoclonal antibodyFeline
GM-Tg-cang-IP2594-Ab-1/ GM-Tg-cang-IP2594-Ab-2Anti-Canine MEPCE monoclonal antibodyCanine
GM-Tg-bovg-IP2594-Ab-1/ GM-Tg-bovg-IP2594-Ab-2Anti-Bovine MEPCE monoclonal antibodyBovine
GM-Tg-equg-IP2594-Ab-1/ GM-Tg-equg-IP2594-Ab-2Anti-Equine MEPCE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2594-Ab-1/ GM-Tg-hg-IP2594-Ab-2; GM-Tg-rg-IP2594-Ab-1/ GM-Tg-rg-IP2594-Ab-2;
GM-Tg-mg-IP2594-Ab-1/ GM-Tg-mg-IP2594-Ab-2; GM-Tg-cynog-IP2594-Ab-1/ GM-Tg-cynog-IP2594-Ab-2;
GM-Tg-felg-IP2594-Ab-1/ GM-Tg-felg-IP2594-Ab-2; GM-Tg-cang-IP2594-Ab-1/ GM-Tg-cang-IP2594-Ab-2;
GM-Tg-bovg-IP2594-Ab-1/ GM-Tg-bovg-IP2594-Ab-2; GM-Tg-equg-IP2594-Ab-1/ GM-Tg-equg-IP2594-Ab-2
Products NameAnti-MEPCE monoclonal antibody
Formatmab
Target NameMEPCE
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MEPCE monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2594-Ag-1Recombinant multi-species MEPCE/ BCDIN3 protein
    ORF Viral VectorpGMLP004022human MEPCE Lentivirus plasmid
    ORF Viral VectorvGMLP004022human MEPCE Lentivirus particle


    Target information

    Target IDGM-IP2594
    Target NameMEPCE
    Gene ID56257,231803,304361,711829,489839,101090162,519969,100068939
    Gene Symbol and SynonymsBCDIN3,D5Wsu46e,MEPCE
    Uniprot AccessionQ7L2J0
    Uniprot Entry NameMEPCE_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000146834
    Target ClassificationN/A

    The target: MEPCE, gene name: MEPCE, also named as BCDIN3. Enables 7SK snRNA binding activity and RNA 5'-methyltransferase activity. Involved in RNA modification; positive regulation of protein localization to Cajal body; and positive regulation of snRNA transcription by RNA polymerase II. Located in nucleus. Part of 7SK snRNP. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.